FENC vs SYF · rev $17.9M vs rev $11.19B
Fennec Pharmaceuticals Inc (FENC) versus SYF (SYF) — a side-by-side from cached financials, not a winner call.
Fennec Pharmaceuticals Inc (FENC) is a biotechnology company listed on US.
SYF (SYF) common stock.
Latest reported FENC revenue for 2026-06-30 was $17.9M. Net income was $2.0M. Revenue was up 18.3% from 2026-03-31 to 2026-06-30. FENC currently screens at market cap $302.2M.
Latest reported SYF revenue for 2026-06-30 was $11.19B. Net income was $1.69B. Revenue was up 99.6% from 2026-03-31 to 2026-06-30. SYF currently screens at market cap $0.
FENC currently screens at market cap $302.2M. SYF currently screens at market cap $0.
Not investment advice. Open the FENC and SYF stock pages for the full models.
Not investment advice.